BlackRock »

Skye Bioscience shares owned by BlackRock

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.0M 1.1M 8.01

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
Henderson Group
Vanguard Group
CVI Holdings
Driehaus Capital Management
Point72 Asset Management
Baker Bros. Advisors
Perceptive Advisors
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Skye Bioscience